Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Vivo Opportunity, LLC | 10% Owner | Apr 30 '24 | Sale | 45.13 | 351,242 | 15,851,551 | 7,316,851 | May 01 01:10 PM | Vivo Opportunity, LLC | 10% Owner | Apr 29 '24 | Sale | 47.80 | 750,000 | 35,850,000 | 7,668,093 | May 01 01:10 PM | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Apr 01 '24 | Sale | 41.34 | 18,980 | 784,645 | 152,790 | Apr 03 09:36 PM | Mackaness James H | CHIEF FINANCIAL OFFICER | Apr 01 '24 | Sale | 41.34 | 5,175 | 213,937 | 62,953 | Apr 03 09:39 PM | Yen Kristen | SEE REMARKS | Apr 01 '24 | Sale | 41.34 | 2,218 | 91,694 | 23,422 | Apr 03 09:40 PM | Hirano Patricia C | SEE REMARKS | Apr 01 '24 | Sale | 41.34 | 2,218 | 91,694 | 41,812 | Apr 03 09:37 PM | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Jan 25 '24 | Sale | 48.30 | 2,527 | 122,054 | 171,770 | Jan 29 05:42 PM | Hirano Patricia C | SEE REMARKS | Jan 25 '24 | Sale | 48.30 | 832 | 40,186 | 43,142 | Jan 29 05:44 PM | Yen Kristen | SEE REMARKS | Jan 25 '24 | Sale | 48.30 | 397 | 19,175 | 25,640 | Jan 29 05:47 PM | Hirano Patricia C | See Remarks | Dec 14 '23 | Sale | 36.49 | 1,359 | 49,584 | 19,974 | Dec 15 06:00 PM | Yen Kristen | See Remarks | Dec 13 '23 | Option Exercise | 2.55 | 17,916 | 45,644 | 19,953 | Dec 14 07:57 PM | Yen Kristen | See Remarks | Dec 13 '23 | Sale | 37.76 | 17,916 | 676,557 | 2,037 | Dec 14 07:57 PM | Hirano Patricia C | See Remarks | Dec 13 '23 | Sale | 38.79 | 4,885 | 189,513 | 21,333 | Dec 15 06:00 PM | Yen Kristen | See Remarks | Dec 12 '23 | Sale | 36.95 | 19,913 | 735,874 | 2,037 | Dec 14 07:57 PM | Mackaness James H | Chief Financial Officer | Dec 11 '23 | Option Exercise | 2.60 | 15,000 | 38,925 | 44,610 | Dec 13 09:34 PM | Anish Bhatnagar | Chief Executive Officer | Dec 11 '23 | Sale | 35.67 | 93,408 | 3,331,701 | 24,297 | Dec 13 09:34 PM | Mackaness James H | Chief Financial Officer | Dec 11 '23 | Sale | 36.41 | 32,482 | 1,182,828 | 12,128 | Dec 13 09:34 PM | Anish Bhatnagar | Chief Executive Officer | Nov 30 '23 | Sale | 28.65 | 27,716 | 794,116 | 108,062 | Dec 04 08:02 PM | Mackaness James H | Chief Financial Officer | Nov 30 '23 | Sale | 28.65 | 4,186 | 119,937 | 21,303 | Dec 04 08:04 PM | Yen Kristen | See Remarks | Nov 30 '23 | Sale | 28.65 | 3,963 | 113,547 | 21,950 | Dec 04 08:06 PM | Hirano Patricia C | See Remarks | Nov 30 '23 | Sale | 28.65 | 3,823 | 109,536 | 26,218 | Dec 04 08:03 PM | Anish Bhatnagar | Chief Executive Officer | Nov 29 '23 | Sale | 27.83 | 27,827 | 774,535 | 135,778 | Nov 30 09:50 PM | Mackaness James H | Chief Financial Officer | Nov 29 '23 | Sale | 27.83 | 4,203 | 116,986 | 25,489 | Nov 30 09:52 PM | Yen Kristen | See Remarks | Nov 29 '23 | Sale | 27.83 | 3,979 | 110,751 | 25,913 | Nov 30 09:52 PM | Hirano Patricia C | See Remarks | Nov 29 '23 | Sale | 27.83 | 3,839 | 106,855 | 30,041 | Nov 30 09:51 PM | Anish Bhatnagar | Chief Executive Officer | Nov 28 '23 | Sale | 27.12 | 25,678 | 696,514 | 163,605 | Nov 30 09:50 PM | Mackaness James H | Chief Financial Officer | Nov 28 '23 | Sale | 27.12 | 3,878 | 105,190 | 29,692 | Nov 30 09:52 PM | Yen Kristen | See Remarks | Nov 28 '23 | Sale | 27.12 | 3,671 | 99,575 | 29,892 | Nov 30 09:52 PM | Hirano Patricia C | See Remarks | Nov 28 '23 | Sale | 27.12 | 3,542 | 96,076 | 33,880 | Nov 30 09:51 PM | Anish Bhatnagar | Chief Executive Officer | Oct 20 '23 | Option Exercise | 3.16 | 9,643 | 30,500 | 198,926 | Dec 13 09:32 PM | Mackaness James H | Chief Financial Officer | Oct 02 '23 | Option Exercise | 2.95 | 8,309 | 24,497 | 41,879 | Dec 13 09:32 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Sep 28 '23 | Buy | 20.00 | 250,000 | 5,000,000 | 3,074,542 | Sep 28 03:45 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Sep 26 '23 | Buy | 16.40 | 616,789 | 10,113,916 | 2,824,542 | Sep 28 03:45 PM |
|